News Features Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding Yael L. Maxwell June 29, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Conference News EuroPCR 2016 Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access Michael O'Riordan May 19, 2016
News Conference News SCAI 2016 Dual Circulation Assessment, Low Volume Each Do a Disservice to Radial Access L.A. McKeown May 05, 2016
News Daily News Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion Shelley Wood April 18, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Industry News CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN March 17, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Daily News Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI Todd Neale December 14, 2015
News Industry News Xeltis Completed Second Feasibility Clinical Trial on Bioabsorbable Cardiovascular Device Technology November 09, 2015
News Industry News Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial October 27, 2015
News Conference News TCT 2015 Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials October 13, 2015
News Conference News TCT 2015 Despite Setbacks, Research Into Myocardial Salvage Continues October 12, 2015
News Conference News TCT 2015 BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective October 12, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015